Prostatic Hyperplasia Treatment & Cancer Prevention

See also
Status	Clinical Trial	Phase
Completed	`NCT02578953` - Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects	Phase 1
Terminated	`NCT02396420` - Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams	Phase 2
Terminated	`NCT04398966` - Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia	N/A
Not yet recruiting	`NCT06452927` - EEP in Patients With Urodynamically Proven DU/DA	N/A
Completed	`NCT02947958` - Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia	N/A
Completed	`NCT01937871` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)	Phase 3
Completed	`NCT00427882` - Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study	Phase 4
Completed	`NCT02244320` - Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)	N/A
Completed	`NCT01254071` - A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.	Phase 1
Recruiting	`NCT04108871` - Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men	N/A
Recruiting	`NCT05686525` - Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men With BPH	N/A
Completed	`NCT01957189` - This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples	Phase 1
Completed	`NCT00316732` - Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS	N/A
Completed	`NCT02715401` - PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers	Phase 1
Recruiting	`NCT02278679` - Digital Rectal Exam Proficiency Tool	N/A
Completed	`NCT01376258` - Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database	N/A
Completed	`NCT01482676` - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction	N/A
Completed	`NCT00822952` - Prostate Mechanical Imager (PMI) Clinical Bridging Study	N/A
Completed	`NCT00527605` - Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)	Phase 3
Terminated	`NCT00563654` - Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up	N/A

NCT number	NCT03064282
Study type	Interventional
Source	Manchanda Medical Clinic
Contact
Status	Not yet recruiting
Phase	Early Phase 1
Start date	June 30, 2021
Completion date	December 1, 2021

Prostatic Hyperplasia Treatment and Cancer Prevention

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms